Download
1 / 2
20 likes | 32 Views
We are organizing a webinar on u201cAlzheimeru2019s Roadmap: Addressing the challenges for improved outcomes,u201d which will primarily focus on the market scenario addressing the significant hurdles the pharmaceutical companies face and how they can be addressed. The webinar will be conducted on 6th June 2023 for Europe at 05:00 PM CEST and for the US at 8:00 AM PDT.<br><br>Limited Seats Available! Visit below link for more information. Register now@<br>https://www.iebrain.com/webinars/Alzheimers-Roadmap/
E N D
Live Webinar - Alzheimer’s Roadmap: Addressing the challengesforImproved Outcomes Weareorganizingawebinaron“Alzheimer’sRoadmap: Addressingthe challengesfor improved outcomes,”whichwillprimarilyfocus onthemarket scenarioaddressingthe significant hurdles the pharmaceutical companies face and how they can be addressed. The webinar will be conducted on 6th June 2023 for Europe at 05:00 PM CEST and for the US at 8:00AM PDT. Alzheimer’s disease (AD) was not the most researched indication among pharma/biopharma companies until the US 2020 census declared that the prevalence of clinical AD could be 11.3%.AspertheAlzheimer’sAssociation,morethan6millionpeopleintheUSarelivingwith the indication, and over 11 million Americans are providing unpaid care for people with Alzheimer’s or other dementias. Between 2000 and 2019, the death rate from Alzheimer’s increased by 145%, with a projected healthcare cost of USD 345 Billion in 2023. Analysts also suggest that the costcouldrisetonearly USD1Trillion. This could be a huge burden to the US healthcare system, and the administration might have todealwithsignificantlogisticalanddiagnosticchallenges.Also, withreferencetothe decision-making for the drug, the diagnosis & detection rate is slower than other indications, whichcreatesahugegapinthemarketinprescribingthe medicationbyphysicians. Speakers: SibasishDuttaChoudhuriandHiteshGupta This webinar will unfold the opportunities for various pharmaceutical or biopharmaceutical companies to fully understand the key challenges and advances for Alzheimer’s. What is the major challenge concerning the market, and why could only a few drugs make it to the market? Ourspeakerswillthoroughlydiscussthekeyaspectsofcompetitionand opportunitiesin themarket.Besidesthis,there willalsobe adiscussiononstrategic approaches to be taken by pharmaceutical, health insurance, and physicians to help them mitigate the burdenofthe disease. LimitedSeatsAvailable!Visit belowlinkformoreinformation.Registernow@ https://www.iebrain.com/webinars/Alzheimers-Roadmap/ About Ingeniouse-Brain Solutions:- Ingenious e-BrainSolutions provideshigh-quality, customized,andcost-effective Technology Intelligence,BusinessIntelligence, and IntellectualPropertyIntelligencesolutions to industry leaders, and innovative companies across the globe. Innovation, knowledge, and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide highest quality results ensuring fool-proof confidentiality and security. We are an ISO certified company withoffices inIndiaandUSA.
Ingeniouse-BrainSolutionshasastrongteamofanalysts,andsubjectmatterexpertswithdomain proficiency which is devoted to help clients grow. Our highly qualified professionals offer tailored, value-addedand cost-effective servicestoour clients.Webelieve inbuildinglongterm relationships with our clients who include national and international corporations, Fortune 500 companies, world’s leading research institutes and universities as well as independent inventors. Get in Touch:- IndiaOffice 207-208 Welldone TechPark, Sohna Road Sector48,Gurugram, Haryana122018,India +91124 429 4218 Email:- queries@iebrain.com
